Related Experiment Video
Updated: Dec 14, 2025

10:27
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
1.9K
Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases
Valeria Lodde1, Giampaolo Murgia1, Elena Rita Simula1
1Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.
Biomolecules
|July 18, 2020
Summary
Noncoding RNAs (ncRNAs) play a crucial role in regulating gene expression and are implicated in autoimmune diseases (ADs). Understanding ncRNA
Area of Science:
- Immunology and Genetics
- Molecular Biology
Background:
- Autoimmune diseases (ADs) arise from uncontrolled immune responses targeting self-tissues, causing chronic inflammation and damage.
- Current AD treatments primarily manage symptoms, with no definitive cures available despite extensive research.
- Genome-wide association studies have identified numerous genetic loci linked to ADs, but the complete molecular pathogenesis remains elusive.
Purpose of the Study:
- To review the potential roles and genetic regulation of noncoding RNAs (ncRNAs) in ADs.
- To highlight ncRNAs as potential therapeutic targets and biomarkers for ADs.
- To focus on ncRNA involvement in systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and type 1 diabetes mellitus.
Main Methods:
- Literature review focusing on ncRNAs (microRNAs, circRNAs, lncRNAs) in autoimmune diseases.
- Analysis of genetic regulation mechanisms of ncRNAs in disease pathogenesis.
- Synthesis of current knowledge on ncRNA functions and therapeutic potential.
Main Results:
- Noncoding RNAs (ncRNAs) are key regulators of gene expression across various cellular processes.
- Dysregulation of ncRNAs is increasingly recognized as a significant factor in the development and progression of ADs.
- Specific ncRNAs show promise as diagnostic biomarkers and therapeutic targets for ADs.
Conclusions:
- Noncoding RNAs represent a critical, yet underexplored, area in autoimmune disease research.
- Targeting ncRNAs offers novel therapeutic strategies for currently incurable autoimmune conditions.
- Further investigation into ncRNA genetics and function is essential for advancing AD treatment and management.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs
3.2K
3.2K
Autoimmune Disorders
1.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.3K
Types of RNA
8.6K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
8.6K
Types of RNA
72.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.1K
Ribosomal RNA Synthesis
14.3K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.3K

